These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6595483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP, Peters WG, Willemze R.
    Cancer Res; 1986 Aug; 46(8):3825-7. PubMed ID: 3460691
    [Abstract] [Full Text] [Related]

  • 3. Cell kinetic studies after high dose Ara-C and adriamycin treatment in a slowly growing rat leukemia model (BNML) for human acute myelocytic leukemia.
    Colly LP, van Bekkum DW, Hagenbeek A.
    Leuk Res; 1984 Aug; 8(6):945-52. PubMed ID: 6595482
    [Abstract] [Full Text] [Related]

  • 4. In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML).
    Colly LP, Willemze R, Honders W, vd Hoorn F, Edelbroek PM.
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):49-54. PubMed ID: 3859932
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity of doxorubicin for normal hematopoietic and acute myeloid leukemia cells of the rat.
    Sonneveld P, Mulder Ja, van Bekkum DW.
    Cancer Chemother Pharmacol; 1981 Jun; 5(3):167-73. PubMed ID: 6945921
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.
    Richel DJ, Colly LP, Lurvink E, Willemze R.
    Br J Cancer; 1988 Dec; 58(6):730-3. PubMed ID: 2465015
    [Abstract] [Full Text] [Related]

  • 7. Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat model.
    Vaughan WP, Burke PJ.
    Cancer Res; 1983 May; 43(5):2005-9. PubMed ID: 6572561
    [Abstract] [Full Text] [Related]

  • 8. Cryopreservation of autologous marrow grafts in acute leukemia: survival of in vivo clonogenic leukemic cells and normal hemopoietic stem cells.
    Hagenbeek A, Martens AC.
    Leukemia; 1989 Jul; 3(7):535-7. PubMed ID: 2659904
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
    Fountzilas G, Inoue S, Ohnuma T.
    Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.
    Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J, Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2020 May; 39(10-12):1346. PubMed ID: 32727269
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro sensitivity of CFU-L to cytosine arabinoside (Ara-C).
    Marie JP, Zittoun R.
    Med Pediatr Oncol; 1982 May; 10 Suppl 1():263-7. PubMed ID: 6962323
    [Abstract] [Full Text] [Related]

  • 17. Acetyldinaline: a new oral cytostatic drug with impressive differential activity against leukemic cells and normal stem cells--preclinical studies in a relevant rat model for human acute myelocytic leukemia.
    el-Beltagi HM, Martens AC, Lelieveld P, Haroun EA, Hagenbeek A.
    Cancer Res; 1993 Jul 01; 53(13):3008-14. PubMed ID: 8319208
    [Abstract] [Full Text] [Related]

  • 18. Treatment of acute myelocytic leukemia with interleukin-6 Pseudomonas exotoxin fusion protein in a rat leukemia model.
    Rozemuller H, Rombouts WJ, Touw IP, FitzGerald DJ, Kreitman RJ, Pastan I, Hagenbeek A, Martens AC.
    Leukemia; 1996 Nov 01; 10(11):1796-803. PubMed ID: 8892684
    [Abstract] [Full Text] [Related]

  • 19. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation.
    te Boekhorst PA, Löwenberg B, Vlastuin M, Sonneveld P.
    Leukemia; 1993 Aug 01; 7(8):1191-8. PubMed ID: 7688839
    [Abstract] [Full Text] [Related]

  • 20. Effects of mast cell growth factor on Ara-C mediated acute myeloid leukemia cell killing.
    Tafuri A, De Felice L, Mascolo MG, Valentini T, Petrucci MT, Petti MC.
    Stem Cells; 1993 Jul 01; 11 Suppl 2():88-92. PubMed ID: 7691332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.